DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
Products offered on a not-for-profit basis to the 45 lower-income countries now include the full portfolio for which Pfizer has global rights.
To create leading company developing medicines targeting metalloenzymes
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
Global pharmaceutical company having a surgical business concept incepted in Dubai
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated
